Biechele Royce Advisors Decreases Stock Position in Bristol-Myers Squibb (NYSE:BMY)
Biechele Royce Advisors reduced its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 7.6% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 105,677 shares of the biopharmaceutical company’s stock after selling 8,686 shares during the period. Bristol-Myers Squibb comprises approximately […]
United States Pomalyst Imnovid Bristol Myers Squibb Ann Powell True Wealth Design Capital Management Inc
Source: etfdailynews.com